160 related articles for article (PubMed ID: 24950778)
1. Impact of the healthcare payment system on patient access to oral anticancer drugs: an illustration from the French and United States contexts.
Benjamin L; Buthion V; Vidal-Trécan G; Briot P
BMC Health Serv Res; 2014 Jun; 14():274. PubMed ID: 24950778
[TBL] [Abstract][Full Text] [Related]
2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
3. Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?
Bonastre J; Chevalier J; Van der Laan C; Delibes M; De Pouvourville G
Health Policy; 2014 Jun; 116(2-3):162-9. PubMed ID: 24314625
[TBL] [Abstract][Full Text] [Related]
4. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
[TBL] [Abstract][Full Text] [Related]
5. Providing prescription drug coverage to the elderly: America's experiment with Medicare Part D.
Duggan M; Healy P; Morton FS
J Econ Perspect; 2008; 22(4):69-92. PubMed ID: 19768843
[No Abstract] [Full Text] [Related]
6. Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?
Mason A; Drummond M; Ramsey S; Campbell J; Raisch D
J Clin Oncol; 2010 Jul; 28(20):3234-8. PubMed ID: 20498408
[TBL] [Abstract][Full Text] [Related]
7. Physician payment 2008 for interventionalists: current state of health care policy.
Manchikanti L; Giordano J
Pain Physician; 2007 Sep; 10(5):607-26. PubMed ID: 17876359
[TBL] [Abstract][Full Text] [Related]
8. Hospital reimbursement price cap for cancer drugs: the French experience in controlling hospital drug expenditures.
Degrassat-Théas A; Bensadon M; Rieu C; Angalakuditi M; Le Pen C; Paubel P
Pharmacoeconomics; 2012 Jul; 30(7):565-73. PubMed ID: 22686661
[TBL] [Abstract][Full Text] [Related]
9. The effects of the coverage gap on drug spending: a closer look at Medicare Part D.
Zhang Y; Donohue JM; Newhouse JP; Lave JR
Health Aff (Millwood); 2009; 28(2):w317-25. PubMed ID: 19189991
[TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
11. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
Newell S; Jordan Z
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Care: Funding of Long-Term Care.
Seiler LW; Fleming JA;
Issue Brief Health Policy Track Serv; 2015 Dec; ():1-52. PubMed ID: 27116783
[No Abstract] [Full Text] [Related]
13. Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019.
Dusetzina SB; Huskamp HA; Keating NL
JAMA; 2019 May; 321(20):2025-2027. PubMed ID: 31135837
[TBL] [Abstract][Full Text] [Related]
14. What can the Canadians and Americans learn from each other's health care systems?
Weil TP
Int J Health Plann Manage; 2016 Jul; 31(3):349-70. PubMed ID: 27469581
[TBL] [Abstract][Full Text] [Related]
15. Prescription drug coverage among elderly and disabled Americans: can Medicare-Part D reduce inequities in access?
Kanavos P; Gemmill-Toyama M
Int J Health Care Finance Econ; 2010 Sep; 10(3):203-18. PubMed ID: 20213234
[TBL] [Abstract][Full Text] [Related]
16. The impact of National Health Insurance upon accessibility of health services and financial protection from catastrophic health expenditure: a case study of Savannakhet province, the Lao People's Democratic Republic.
Bodhisane S; Pongpanich S
Health Res Policy Syst; 2019 Dec; 17(1):99. PubMed ID: 31842882
[TBL] [Abstract][Full Text] [Related]
17. Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2019 Rates; Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs (Promoting Interoperability Programs) Requirements for Eligible Hospitals, Critical Access Hospitals, and Eligible Professionals; Medicare Cost Reporting Requirements; and Physician Certification and Recertification of Claims. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2018 Aug; 83(160):41144-784. PubMed ID: 30192475
[TBL] [Abstract][Full Text] [Related]
18. Health USA. A national health program for the United States.
Brown ER
JAMA; 1992 Jan 22-29; 267(4):552-8. PubMed ID: 1729579
[TBL] [Abstract][Full Text] [Related]
19. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2015 rates; quality reporting requirements for specific providers; reasonable compensation equivalents for physician services in excluded hospitals and certain teaching hospitals; provider administrative appeals and judicial review; enforcement provisions for organ transplant centers; and electronic health record (EHR) incentive program. Final rule.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2014 Aug; 79(163):49853-50536. PubMed ID: 25167590
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
